EGFR and non-small cell lung carcinoma: Genetic analysis of NSCLC revealed that the EGFR and its downstream targets, the members of the mitogenic RAS/RAF/MEK/ERK signalling cascade, are frequently mutated or overexpressed in NSCLC types of tumours.